New studies on the treatment of genitourinary cancers were released today in advance of the third annual Genitourinary Cancers Symposium, being held March 5-7, 2010, at the San Francisco Marriott…

Next generation technology is set to revolutionize medical imaging by enabling earlier detection of brain tumors with one scan, improving the diagnosis and therapy of cancer, and increasing patient throughput in hospitals, according to news of a pioneering UK project…

The signaling molecule CD95L, known as “death messenger,” causes an inflammatory process in injured tissue after spinal cord injuries and prevents its healing. This discovery was published by scientists of the German Cancer Research Center. In mice, the researchers found out that if they switch off CD95L, the injured spinal cord heals and the animals [...]

A low-cost water purification technique published in Current Protocols in Microbiology could help drastically reduce the incidence of waterborne disease in the developing world. The procedure, which uses seeds from the Moringa oleifera tree, can produce a 90.00% to 99…

A Refugees International report, released on Tuesday, says U.N. aid efforts in Haiti since the earthquake have not been sufficiently coordinated with local groups, the New York Times reports. Among other things, the lack of coordinated response has enabled sexual abuse of women and girls in temporary camps, according to Emilie Parry, an aid consultant [...]

As part of her trip to Latin America, Secretary of State Hillary Rodham Clinton handed out 25 satellite phones on Tuesday in Chile and said the U.S. would help “in any way the government of Chile asks us to,” the Washington Times reports (3/3)…

The New York Times on Tuesday examined how former Rep. Harold Ford (D-Tenn.) came to concede that a campaign against Sen. Kirsten Gillibrand (D-N.Y.) in the Democratic primary “would be a brutal fight dominated by endless debates about when he began paying taxes as a New Yorker and the sincerity of his support for gay [...]

Dendreon Corporation (Nasdaq: DNDN) announced updated results from its pivotal Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study demonstrating that PROVENGE® (sipuleucel-T) extends overall survival in men with metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC)…

BARRX Medical, Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its HALO90 Ablation Catheter for the treatment of Radiation Proctitis (RP) and Gastric Antral Vascular Ectasia (GAVE). Both conditions are diseases of the gastrointestinal tract associated with chronic bleeding and the need for blood [...]

North Carolina House Minority Leader Paul Stam (R) “is a committed, passionate and effective opponent of the right of North Carolina women to choose to terminate a pregnancy,” but recently he “has turned to claimed legal mandates, that, on close reading, cannot be justified,” according to a Raleigh News & Observer opinion piece by Gene [...]